Skip to main content
Signal8
Catelani Michael profile photo

Michael Catelani

CIK: 0001689394

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Anixa Biosciences Inc logo
ANIX

Anixa Biosciences Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Anixa Biosciences Inc logo
    ANIX

    Anixa Biosciences Inc

    Jan 5, 2026
    Award(A)

    Employee Stock Option

    Direct
    175K shares-
  • Anixa Biosciences Inc logo
    ANIX

    Anixa Biosciences Inc

    Jan 15, 2025
    Purchase(P)
    Direct
    9.3K shares at avg. $2.15$20K
  • Anixa Biosciences Inc logo
    ANIX

    Anixa Biosciences Inc

    Jan 2, 2025
    Award(A)

    Employee Stock Option

    Direct
    350K shares-

1-3 of 3

About Catelani Michael

Catelani Michael (SEC CIK 0001689394) files insider reports with the SEC as President, COO & CFO of Anixa Biosciences Inc (ANIX).

Signal8 holds 3 ownership filings by Catelani Michael, all Form 4s, filed between Jan 3, 2025 and Jan 6, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jan 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Catelani Michael's filings is in SAN JOSE,, CA.

Recent filings by Catelani Michael

  • Jan 5, 2026: Grant or award of ANIX derivative securities (Form 4, code A).
  • Jan 15, 2025: Open-market purchase of ANIX shares (Form 4, code P).
  • Jan 2, 2025: Grant or award of ANIX derivative securities (Form 4, code A).

Other insiders filing for Anixa Biosciences Inc (ANIX)

How to read Form 4 transaction codes